On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study - Quiz - MDSpire

On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study

  • By

  • Ryo Nakano

  • Ayumi Ichisawa

  • Kenya Saruta

  • Masakazu Kogawa

  • Akira Fukuda

  • June 17, 2026

  • 0 min

Share

Original Source(s)

On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study

  • by Ryo Nakano, Ayumi Ichisawa, Kenya Saruta, Masakazu Kogawa, Akira Fukuda

  • June 17, 2026

Related Content

Development and Experimental Validation of an Osteoporosis Diagnosis Model Based on Disulfidoptosis-related Genes and Immune Infiltration Analysis

Linking the relationship between drug-induced osteoporosis and the gut microbiota

Correction: The association between the triglyceride-glucose index and bone turnover markers in osteoporotic fractures patients aged 50 and above who are hospitalized for surgical intervention: a retrospective cross-sectional study